Financhill
Back

Supernus Pharmaceuticals, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Supernus Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 48.12 Buy
20-day SMA: 46.51 Buy
50-day SMA: 48.32 Buy
200-day SMA: 39.33 Buy
8-day EMA: 26.51 Buy
20-day EMA: 12.95 Buy
50-day EMA: 5.64 Buy
200-day EMA: 1.47 Buy

Supernus Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.42 Buy
Relative Strength Index (14 RSI): 68.86 Buy
Chaikin Money Flow: 1126101 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.54 - 47.92) Buy
Bollinger Bands (100): (42.5 - 50.32) Buy

Supernus Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Supernus Pharmaceuticals, Inc. Stock

Is Supernus Pharmaceuticals, Inc. Stock a Buy?

SUPN Technical Analysis vs Fundamental Analysis

Buy
53
Supernus Pharmaceuticals, Inc. (SUPN) is a Buy

Is Supernus Pharmaceuticals, Inc. a Buy or a Sell?

Supernus Pharmaceuticals, Inc. Stock Info

Market Cap:
3B
Price in USD:
51.48
Share Volume:
1.6M

Supernus Pharmaceuticals, Inc. 52-Week Range

52-Week High:
57.65
52-Week Low:
29.16
Buy
53
Supernus Pharmaceuticals, Inc. (SUPN) is a Buy

Supernus Pharmaceuticals, Inc. Share Price Forecast

Is Supernus Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Supernus Pharmaceuticals, Inc.

Is Supernus Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.43 per share.

Technical Analysis of Supernus Pharmaceuticals, Inc.

Should I short Supernus Pharmaceuticals, Inc. stock?

* Supernus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.